Meisam Rezaei

535 citations
5 papers · 464 indexed · h-index 5
Topics
Alzheimer's disease research and treatments (3 papers)Prion Diseases and Protein Misfolding (2 papers)Cholinesterase and Neurodegenerative Diseases (1 paper)
Partner nations
IranIrelandUnited States

In The Last Decade

Meisam Rezaei

5 papers receiving 463 citations

Peers

Meisam Rezaei
Comparison fields: 5 of 74
  • Biomaterials 251
  • Molecular Biology 161
  • Materials Chemistry 158
  • Biomedical Engineering 153
  • Physiology 84
Replace Sonia Goy‐López with:
Sonia Goy‐López Spain
Judith J. Mittag Germany
Slaven Radic United States
Jürgen Linders Germany
Atanu Chakraborty India
Scott C. Radzinski United States
Aidan K. Wright United States
Chris Sosa United States
Masayoshi Asai Japan
Effie Y. Zhou United States
Meisam Rezaei relative to Sonia Goy‐López Spain Sonia Goy‐López's profile →
Citations per field
00.5×3.2×
Sonia Goy‐López · 1×
Citations per year

Countries citing papers authored by Meisam Rezaei

Since Specialization
Citations

This map shows the geographic impact of Meisam Rezaei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meisam Rezaei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meisam Rezaei more than expected).

Fields of papers citing papers by Meisam Rezaei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meisam Rezaei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meisam Rezaei. The network helps show where Meisam Rezaei may publish in the future.

Co-authorship network of co-authors of Meisam Rezaei

This figure shows the co-authorship network connecting the top 25 collaborators of Meisam Rezaei. A scholar is included among the top collaborators of Meisam Rezaei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meisam Rezaei. Meisam Rezaei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 47
2 281
3 43
4 56
5 37

About Meisam Rezaei

Meisam Rezaei is a scholar working on Biochemistry, Physiology and Physical and Theoretical Chemistry, having authored 5 papers that have together received 464 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (3 papers), Prion Diseases and Protein Misfolding (2 papers) and Cholinesterase and Neurodegenerative Diseases (1 paper). The work is most often cited by research in Biomaterials (251 citations), Surfaces, Coatings and Films (75 citations) and Biomedical Engineering (153 citations). Meisam Rezaei has collaborated with scholars based in Iran, Ireland and United States. Frequent co-authors include Morteza Mahmoudi, Mohammad Reza Ejtehadi, Mohammad Ali Shokrgozar, Joachim H. Clement, Shahed Behzadi, Scott Metzler, Vahid Serpooshan, Christian Pfeiffer, G. Ulrich Nienhaus and Pilar Ruiz‐Lozano. Their work appears in journals such as ACS Nano, RSC Advances and ChemBioChem.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026